Acadia Pharmaceuticals Stock
Price
Target price
€14.14
€14.14
-3.080%
-0.45
-3.080%
€31.78
14:35 / Tradegate
WKN: 603035 / Symbol: ACAD / Name: ACADIA Pharm / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Acadia Pharmaceuticals Stock
Heavy losses for Acadia Pharmaceuticals today as the stock fell by -€0.450 (-3.080%).
With 28 Buy predictions and 1 Sell predictions Acadia Pharmaceuticals is one of the favorites of our community.
Based on the current price of 14.14 € the target price of 31 € shows a potential of 119.24% for Acadia Pharmaceuticals which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Acadia Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | -3.080% | -6.564% | -11.091% | -25.939% | -48.627% | -15.786% | -37.610% |
| Ironwood Pharmaceuticals | - | -2.597% | 2.740% | -20.213% | -26.471% | -17.582% | - |
| Sage Therapeutics Inc. | 0.610% | -5.608% | -24.269% | -75.151% | -42.350% | -80.719% | - |
| Novocure Ltd | -1.990% | 14.297% | 10.171% | -76.039% | 5.849% | -90.449% | - |
Comments
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at HC Wainwright from $33.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
